• CUDC-907: Practical PI3K/HDAC Workflow Guide

  2026-08-26

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled cell-based studies of PI3K/AKT signaling, histone deacetylase activity, apoptosis, and cell-cycle regulation. This guide covers formulation, starting treatment conditions, assay controls, and interpretation limits; the compound is for scientific research only and should not be used diagnostically or clinically.

• 3-Hydroxybutyrate (BHBA) in Cell Assays

  2026-08-25

  Learn how 3-hydroxybutyrate (BHBA), SKU M1297, can be incorporated into reproducible cell viability, metabolic-stress, and ferroptosis workflows. This scenario-based guide links assay design, solution handling, data interpretation, and vendor selection to current ketone-body evidence.

• Propidium Iodide Workflows for Cell Analysis

  2026-08-25

  Build more reliable viability, apoptosis, and cell-cycle experiments with Propidium iodide, a membrane-exclusion DNA intercalating dye suited to microscopy and flow cytometry. A lactoferrin heating study offers a useful process-control lesson: match the treatment history, then use PI as a standardized functional endpoint rather than as a stand-alone mechanistic readout.

• Protease and Phosphatase Inhibitor Cocktail Guide

  2026-08-24

  K4006 helps limit proteolysis and dephosphorylation during biological sample extraction by combining broad protease and phosphatase inhibition in an EDTA-free, 100X aqueous format. It is intended for controlled lysis workflows, but it should not be treated as universal protection against every enzyme or as a substitute for buffer compatibility and assay-specific validation.

• Aβ25-35: From Neurotoxicity to AD Translation

  2026-08-24

  Amyloid Beta-peptide (25-35) is more than a cytotoxicity reagent: it is a controlled perturbation for connecting neuronal injury, oxidative stress, amyloid aggregation, and microglial signaling. This article translates the FLOT1–FOSL2–EphA2 findings into practical assay strategy while defining where the Aβ25-35 model is powerful—and where it should not be overinterpreted.

• RIPostC, Ketone Bodies, and Ferroptosis After Stroke

  2026-08-23

  A 2024 ACS Chemical Neuroscience study identifies ketone body metabolism as a mechanistic link between remote ischemic postconditioning and reduced ferroptotic injury after ischemic stroke. Using rat middle cerebral artery occlusion and oxygen-glucose deprivation/reoxygenation models, the researchers connect improved energy metabolism, preserved GPX4, reduced ACSL4, and lower iron burden with neuroprotection.

• N2-Alkyl-dG Lesions Drive R-Loop Accumulation

  2026-08-22

  Wang and colleagues show that minor-groove N2-alkyl-dG lesions promote R-loop accumulation in chromatin and plasmid DNA, linking DNA alkylation to transcriptional obstruction and genome instability. By combining imaging, R-loop sequencing, transcriptional analyses, and helicase depletion, the study provides a mechanistic framework for understanding how unrepaired alkylated guanine lesions alter nucleic acid metabolism.

• Exosomal SNORD52 Activates JAK2/STAT6 in HCC

  2026-08-21

  The reference study identifies hepatoma cell-derived exosomal SNORD52 as a transferable regulator of macrophage behavior in hepatocellular carcinoma. Its data connect SNORD52 uptake by THP-1 macrophages with M2 polarization and increased JAK2/STAT6 pathway activity, providing a mechanistic framework for studying tumor–immune communication.

• Rapakinin Links PGI₂–IP to CCK1 Vasorelaxation

  2026-08-20

  The reference study identified rapakinin, the Arg-Ile-Tyr peptide from rapeseed protein, as an endothelium-dependent vasorelaxant in mesenteric arteries from spontaneously hypertensive rats. Pharmacological experiments showed that its antihypertensive activity depends mainly on a prostaglandin I₂–IP receptor pathway followed by CCK1 receptor signaling, rather than on nitric oxide or bradykinin B2 receptor activation.

• Fe3O4@ZIF-8 Nanoparticles for Jaw Osteomyelitis

  2026-08-20

  The reference study presents Fe3O4@ZIF-8 core–shell nanoparticles as a dual-function platform for treating jaw osteomyelitis through pH-responsive Zn2+ release, bacterial stress sensitization, and magnetically assisted bone regeneration. Its main translational significance is the integration of infection control and bone repair in one material system, although detailed dosing, safety, and clinical validation remain necessary.

• GW 4869 in Lupus Nephritis Exosome Causality

  2026-08-19

  GW 4869 is more than an exosome release inhibitor: it is a causal perturbation tool for testing how podocyte-derived vesicles injure glomerular endothelial cells in lupus nephritis. This guide connects N-SMase biology, HMGB1 cargo analysis, assay controls, and practical handling of GW 4869 hydrochloride hydrate.

• Irinotecan (CPT-11) in Tumor–Stroma Translation

  2026-08-19

  Irinotecan and its active metabolite SN-38 provide a mechanistic bridge between DNA damage biology and patient-relevant model development. This thought-leadership guide explains how to move from colorectal cancer cell line inhibition to organoid, assembloid, and xenograft strategies while preserving interpretability, formulation control, and translational discipline.

• IL-12 mRNA and the Extrahepatic Delivery Frontier

  2026-08-18

  IL-12 mRNA is becoming a strategic tool for studying localized immune activation, but its translational value depends on more than transcript design. This article connects the engineered features of EZ Cap™ Mouse IL-12 mRNA (m1Ψ) with emerging extrahepatic delivery systems, experimental validation, and practical decision-making for immunotherapy research mRNA programs.

• Pifithrin-α: p53 Inhibition in Ferroptosis Assays

  2026-08-18

  Pifithrin-α (PFTα) provides a practical way to test whether p53 signaling contributes to apoptosis, growth arrest, or ferroptosis-associated injury. This guide translates a recent deltamethrin neurotoxicity study into reproducible cell-assay workflows, controls, optimization steps, and interpretation safeguards.

• Phosphatase Inhibitor Cocktail 1 in HPV Signaling

  2026-08-17

  Phosphatase Inhibitor Cocktail 1 can protect phosphorylation-dependent readouts in HPV-associated cancer research. This article connects phosphatase control with BET-driven signaling heterogeneity and shows how better sample preservation improves assay interpretation without overstating pathway causality.

8447 records 3/564 page Previous Next 12345 下5页 Last page